Last reviewed · How we verify

NCT04547465

2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors

Status unknown Last updated 8 August 2023
What this trial tests

trial testing Echocardiography in Cardiomyopathy Due to Drug in 300 participants. Status unknown.

Timeline
15 September 2020
Primary endpoint
30 October 2023
30 December 2023

Quick facts

Lead sponsorGia Dinh People Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date15 September 2020
Primary completion30 October 2023
Estimated completion30 December 2023
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Gia Dinh People Hospital

Who can join

18 and older, any sex, with Cardiomyopathy Due to Drug or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study is to evaluate the role of 2D speckle-tracking echocardiography in diagnosis chemotherapy related left ventricular dysfunction in breast cancer patients with cardiovascular risks

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain.
    Nhat GM, Hai NH, Duc VT, Tri HHQ, et al · · 2024 · cited 6× · PMID 38312233 · DOI 10.3389/fcvm.2024.1291180

Verify or expand the search:

Other trials of Echocardiography

Trials testing the same drug.

Other recruiting trials for Cardiomyopathy Due to Drug

Currently open trials in the same condition.

Other Gia Dinh People Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04547465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing